TUAB0101 - Atazanavir/ritonavir 200/100 mg is non-inferior to atazanavir/ritonavir 300/100 mg ...
TUAB0101 - Atazanavir/ritonavir 200/100 mg is non-inferior to atazanavir/ritonavir 300/100 mg in virologic suppressed HIV-infected Thai adults: a multicentre, randomized, open-label trial: LASA T. Bunupuradah1, S. Kiertiburanakul2, A. Avihingsanon1,3, P. Chetchotisakd4, M. Techapornroong5, N. Leerattanapetch6, P. Kantipong7, C. Bowonwatanuwong8, S. Banchongkit9, V. Klinbuayaem10, S. Mekviwattanawan11, S. Nimitvilai12, S. Jirajariyavej13, W. Prasithsirikul14, W. Munsakul15, S. Bhakeecheep16, S. Chaivooth16, P. Phanuphak1, D.A. Cooper17, T. Apornpong1, S.J. Kerr1,17, S. Emery17, K. Ruxrungtham1,3, LASA Study Group